drugset / Trial / NCT00603044

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

NCT00603044

Phase 4 Completed 24 enrolled University of Chicago GlaxoSmithKline · collab
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this research is to find out how a nasal spray (fluticasone furoate), sometimes given to children with obstructive sleep apnea syndrome (OSAS), works on certain cells within a child's adenoids. We hypothesize that intranasal steroids lead to an upregulation of T regulatory cells in the adenoid tissues of children with OSAS. This will result in a local reduction in inflammation and edema explaining the improvement in OSAS.

Timeline

Start
2008-01
Primary completion
2009-01
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Furoate Other / unclassified 55 ug Intranasal